|Day Low/High||231.54 / 236.56|
|52 Wk Low/High||208.07 / 287.94|
Here are my five rules for handling earnings season.
Schwab, Domino's, Netflix and UnitedHealth are set to report their quarterly results.
But the fear of missing out is keeping a strong bid under the market.
This matters: Why the sudden 'weakness' across European debt markets?
The indices are in good shape technically, although there was choppy and inconsistent action under the surface Thursday.
A look at the charts and indicators of three big names in the sector .
These managed care stocks can withstand China, politics and a slowdown in the economy.
These are the days when if you're brave you get a good price and begin the ride to greater riches.
As CVS Health's stock continues to run, management's careful approach should be encouraging for beleaguered investors.
The fear will subside around health care stocks, and here is why.
I've spotlighted three blue-chip companies with stock prices that are at ridiculously low valuations right now.
Insurance companies would have their claws in any potential new healthcare law so deep, the law will have slash marks on it.
Especially when healthcare CEOs discus political issues with analysts and reporters.
This health care selloff shows the value of diversification to protect our portfolios -- and to go on the offensive and find bargains.
There is a bloodbath of selling in medical-related names and severe pressure on cloud-related stocks that have been momentum favorites.
Recapping a big day of earnings for both names.
A resilient market allows you to buy stocks when they get hammered and do so with some certainty that you won't get your head handed to you.
The free press that the progressive push for Medicare got on Tuesday morning is hurting the healthcare sector.
UNH's operational strength can't overcome the potential political overhang at the moment.
This is not a stock you want to play around with on the long side.
The health benefit giant's fundamentals are good, but there are more symptoms to consider for a proper examination.
When Netflix reports earnings tonight, what will likely matter above all else for now will be subscriber growth.
Warren Buffett's big bet on kidney dialysis provider DaVita may finally be primed to start paying off, albeit after five frustrating years of negative returns.